Cargando…

Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis

BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to com...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiaodong, Deng, Haoze, Yuan, Jiamin, Hu, Junting, Dai, Lujia, Jiang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096285/
https://www.ncbi.nlm.nih.gov/pubmed/35572911
http://dx.doi.org/10.21037/jtd-22-222
_version_ 1784705941507145728
author Qian, Xiaodong
Deng, Haoze
Yuan, Jiamin
Hu, Junting
Dai, Lujia
Jiang, Tingbo
author_facet Qian, Xiaodong
Deng, Haoze
Yuan, Jiamin
Hu, Junting
Dai, Lujia
Jiang, Tingbo
author_sort Qian, Xiaodong
collection PubMed
description BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to compared the clinical outcomes of PCI and ODT in these patients. METHODS: The following terms were combined to search relative articles through databases PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science published from January 2010 to November 2021 according to Participants, Intervention, Control, Outcomes, Study (PICOS) criteria: “coronary heart disease”, “stable coronary heart disease”, “stable angina pectoris”, “percutaneous coronary intervention”, “PCI”, “percutaneous transluminal coronary angioplasty”, “drug therapy”, “optimized drug treatment”, and “optimized drug therapy”. The meta-analysis was performed by RevMan 5.2, and the Cochrane risk of bias tool was used to evaluate the quality of the included studies. RESULTS: A total of 12 articles were included in the final analysis. There were 4,288 cases of PCI patients and 4,261 cases of ODT patients. The results showed that, when comparing PCI with ODT, there was a significant difference in the probability of myocardial infarction [relative risk (RR) =0.63; 95% confidence intervals (CI): 0.45–0.90] and the patient mortality (RR =0.51; 95% CI: 0.40–0.64). However, there was no significant difference in the prevalence of stroke (RR =1.33; 95% CI: 0.82–2.17), revascularization (RR =0.86; 95% CI: 0.46–1.62) and patient quality of life (MD =10.44; 95% CI: −1.84 to 22.73). Performance bias and detection bias were all unclear in the included studies and should be warned. DISCUSSION: Compared with ODT, PCI reduced the mortality and myocardial infarction rate of patients with CTO or severe coronary artery stenosis. However, the incidence of stroke, revascularization, and quality of life of patients were not significant different between PCI and ODT. Performance bias and detection bias should be cautioned.
format Online
Article
Text
id pubmed-9096285
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-90962852022-05-13 Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis Qian, Xiaodong Deng, Haoze Yuan, Jiamin Hu, Junting Dai, Lujia Jiang, Tingbo J Thorac Dis Original Article BACKGROUND: Many studies have reported potential benefits of percutaneous coronary intervention (PCI) versus optimal drug therapy (ODT) for patients with stable coronary heart disease but with inconsistent results. To examine this, an explicit systematic review and meta-analysis was conducted to compared the clinical outcomes of PCI and ODT in these patients. METHODS: The following terms were combined to search relative articles through databases PubMed, Cochrane Central Register of Controlled Trials, Embase, and Web of Science published from January 2010 to November 2021 according to Participants, Intervention, Control, Outcomes, Study (PICOS) criteria: “coronary heart disease”, “stable coronary heart disease”, “stable angina pectoris”, “percutaneous coronary intervention”, “PCI”, “percutaneous transluminal coronary angioplasty”, “drug therapy”, “optimized drug treatment”, and “optimized drug therapy”. The meta-analysis was performed by RevMan 5.2, and the Cochrane risk of bias tool was used to evaluate the quality of the included studies. RESULTS: A total of 12 articles were included in the final analysis. There were 4,288 cases of PCI patients and 4,261 cases of ODT patients. The results showed that, when comparing PCI with ODT, there was a significant difference in the probability of myocardial infarction [relative risk (RR) =0.63; 95% confidence intervals (CI): 0.45–0.90] and the patient mortality (RR =0.51; 95% CI: 0.40–0.64). However, there was no significant difference in the prevalence of stroke (RR =1.33; 95% CI: 0.82–2.17), revascularization (RR =0.86; 95% CI: 0.46–1.62) and patient quality of life (MD =10.44; 95% CI: −1.84 to 22.73). Performance bias and detection bias were all unclear in the included studies and should be warned. DISCUSSION: Compared with ODT, PCI reduced the mortality and myocardial infarction rate of patients with CTO or severe coronary artery stenosis. However, the incidence of stroke, revascularization, and quality of life of patients were not significant different between PCI and ODT. Performance bias and detection bias should be cautioned. AME Publishing Company 2022-04 /pmc/articles/PMC9096285/ /pubmed/35572911 http://dx.doi.org/10.21037/jtd-22-222 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Qian, Xiaodong
Deng, Haoze
Yuan, Jiamin
Hu, Junting
Dai, Lujia
Jiang, Tingbo
Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title_full Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title_fullStr Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title_full_unstemmed Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title_short Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
title_sort evaluating the efficacy and safety of percutaneous coronary intervention (pci) versus the optimal drug therapy (odt) for stable coronary heart disease: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096285/
https://www.ncbi.nlm.nih.gov/pubmed/35572911
http://dx.doi.org/10.21037/jtd-22-222
work_keys_str_mv AT qianxiaodong evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis
AT denghaoze evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis
AT yuanjiamin evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis
AT hujunting evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis
AT dailujia evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis
AT jiangtingbo evaluatingtheefficacyandsafetyofpercutaneouscoronaryinterventionpciversustheoptimaldrugtherapyodtforstablecoronaryheartdiseaseasystematicreviewandmetaanalysis